File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Article: Effects of empagliflozin on liver fat in metabolic-dysfunction associated steatotic liver disesase patients without diabetes mellitus: a randomized, double-blind, placebo controlled trial

TitleEffects of empagliflozin on liver fat in metabolic-dysfunction associated steatotic liver disesase patients without diabetes mellitus: a randomized, double-blind, placebo controlled trial
Authors
Cheung, KSNg, HYHui, RWHLam, LKMak, LYHo, YCTan, JTChan, EWSeto, WKYuen, MFLeung, WK
Issue Date1-Jan-2024
PublisherLippincott, Williams & Wilkins
Citation
Hepatology, 2024 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/339951
ISSN
0270-9139
2021 Impact Factor: 17.298
2020 SCImago Journal Rankings: 5.488

 

DC FieldValueLanguage
dc.contributor.authorCheung, KS-
dc.contributor.authorNg, HY-
dc.contributor.authorHui, RWH-
dc.contributor.authorLam, LK-
dc.contributor.authorMak, LY-
dc.contributor.authorHo, YC-
dc.contributor.authorTan, JT-
dc.contributor.authorChan, EW-
dc.contributor.authorSeto, WK-
dc.contributor.authorYuen, MF-
dc.contributor.authorLeung, WK-
dc.date.accessioned2024-03-11T10:40:33Z-
dc.date.available2024-03-11T10:40:33Z-
dc.date.issued2024-01-01-
dc.identifier.citationHepatology, 2024-
dc.identifier.issn0270-9139-
dc.identifier.urihttp://hdl.handle.net/10722/339951-
dc.languageeng-
dc.publisherLippincott, Williams & Wilkins-
dc.relation.ispartofHepatology-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleEffects of empagliflozin on liver fat in metabolic-dysfunction associated steatotic liver disesase patients without diabetes mellitus: a randomized, double-blind, placebo controlled trial-
dc.typeArticle-
dc.identifier.eissn1527-3350-
dc.identifier.issnl0270-9139-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats